Jeffrey E. Jacob serves as Executive at Panbela Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey E. Jacob has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 12, 2023 involved gifting 275 shares valued at $0.
Jeffrey E. Jacob currently holds 294,931 shares of Panbela Therapeutics, Inc. (PBLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey E. Jacob has been a net neutral trader of PBLA stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey E. Jacob's most recent insider trade was on Sep 12, 2023, when they sold 275 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |